- Email: [email protected]
The Top Ten
european urology 49 (2006) 929
available at www.sciencedirect.com journal homepage: www.europeanurology.com
The Top Ten Selection of readers’ most popular articles JANUARY (2006) This section highlights the ‘Top Ten’ most read articles. Each list is compiled with a delay of four months from publication. If you only have a few minutes reading time each day – then these are the articles you should look at. 1 Guidelines on Testicular Cancer Albers, P.; Albrecht, W.; Algaba, F.; Bokemeyer, C.; Cohn-Cedermark, G.; Horwich, A.; Klepp, O.; Laguna, M.P.; Pizzocaro, G. European Urology 2005;48:885–894. 2 EAU Guidelines on Prostate Cancer Aus, G.; Abbou, C.C.; Bolla, M.; Heidenreich, A.; Schmid, H.P.; van Poppel, H.; Wolff, J.; Zattoni, F. European Urology 2005;48:546–551. 3 Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer Yri, O.E.; Bjoro, T.; Fossa, S.D. European Urology 2005;49:54–58. 4 Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Rele Jonas, U.; Rackley, R.R. European Urology 2005;49:187–188. 5 Risks and Benefits of Hormonal Manipulation as Monotherapy or Adjuvant Treatment in Localised Prostate Cancer Abrahamsson, P.A.; Anderson, J.; Boccon-Gibod, L.; Schulman, C.; Studer, U.E.; Wirth, M. European Urology 2005;48:900–905.
0302-2838/$ – see back matter
doi:10.1016/S0302-2838(06)00393-9
6 p53 Protein Transduction Therapy: Successful Targeting and Inhibition of the Growth of the Bladder Cancer Cells Inoue, M.; Tomizawa, K.; Matsushita, M.; Lu, Y.F.; Yokoyama, T.; Yanai, H.; Takashima, A.; Kumon, H.; Matsui, H. European Urology 2005;49:161–168. 7 Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement Schro¨der, F.H.; Roobol, M.J.; Boeve´, E.R.; de Mutsert, R.; Zuijdgeest-van Leeuwen, S.D.; Kersten, I.; Wildhagen, M.F.; van Helvoort, A. European Urology 2005;48:922–931. 8 Drug treatment for LUTS and BPH: New is not always better Roehrborn, C.G. European Urology 2005;49:5–7. 9 Sildenafil Non-Responders: Haemodynamic and Morphometric Studies Wespes, E.; Rammal, A.; Garbar, C. European Urology 2005;48:136–139. 10 Androgen Receptor and TGFbeta1/Smad Signaling are Mutually Inhibitory in Prostate Cancer van der Poel, H.G. European Urology 2005;48:1051–1058.
available at www.sciencedirect.com journal homepage: www.europeanurology.com
The Top Ten Selection of readers’ most popular articles JANUARY (2006) This section highlights the ‘Top Ten’ most read articles. Each list is compiled with a delay of four months from publication. If you only have a few minutes reading time each day – then these are the articles you should look at. 1 Guidelines on Testicular Cancer Albers, P.; Albrecht, W.; Algaba, F.; Bokemeyer, C.; Cohn-Cedermark, G.; Horwich, A.; Klepp, O.; Laguna, M.P.; Pizzocaro, G. European Urology 2005;48:885–894. 2 EAU Guidelines on Prostate Cancer Aus, G.; Abbou, C.C.; Bolla, M.; Heidenreich, A.; Schmid, H.P.; van Poppel, H.; Wolff, J.; Zattoni, F. European Urology 2005;48:546–551. 3 Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer Yri, O.E.; Bjoro, T.; Fossa, S.D. European Urology 2005;49:54–58. 4 Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Rele Jonas, U.; Rackley, R.R. European Urology 2005;49:187–188. 5 Risks and Benefits of Hormonal Manipulation as Monotherapy or Adjuvant Treatment in Localised Prostate Cancer Abrahamsson, P.A.; Anderson, J.; Boccon-Gibod, L.; Schulman, C.; Studer, U.E.; Wirth, M. European Urology 2005;48:900–905.
0302-2838/$ – see back matter
doi:10.1016/S0302-2838(06)00393-9
6 p53 Protein Transduction Therapy: Successful Targeting and Inhibition of the Growth of the Bladder Cancer Cells Inoue, M.; Tomizawa, K.; Matsushita, M.; Lu, Y.F.; Yokoyama, T.; Yanai, H.; Takashima, A.; Kumon, H.; Matsui, H. European Urology 2005;49:161–168. 7 Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement Schro¨der, F.H.; Roobol, M.J.; Boeve´, E.R.; de Mutsert, R.; Zuijdgeest-van Leeuwen, S.D.; Kersten, I.; Wildhagen, M.F.; van Helvoort, A. European Urology 2005;48:922–931. 8 Drug treatment for LUTS and BPH: New is not always better Roehrborn, C.G. European Urology 2005;49:5–7. 9 Sildenafil Non-Responders: Haemodynamic and Morphometric Studies Wespes, E.; Rammal, A.; Garbar, C. European Urology 2005;48:136–139. 10 Androgen Receptor and TGFbeta1/Smad Signaling are Mutually Inhibitory in Prostate Cancer van der Poel, H.G. European Urology 2005;48:1051–1058.